Article
Clinical trials of agents that reverse multidrug resistance. A literature review.
Cancer - 15 Dec 1993
Raderer M, Scheithauer W
Abstract excerpt
BACKGROUND: The discovery of the P-170 glycoprotein as a mediator of multidrug resistance (MDR) represents one of the most important research accomplishments in antineoplastic pharmacology during the last decade. Demonstration of P-170 in epithelial tissues, untreated and chemotherapeutically pretreated human malignancies, and identification of various agents capable of reversing resistance in vitro generated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
